T Acute Lymphoblastic Leukemia — Trials

T Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

117 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 47
Recruiting: 28
Ph III recruiting: 2
Growth YoY: —
Industry share: 9%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 52.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07585734	Clinical Trial of CD38 Monoclonal Antibody Combined With Chemotherapy for T-Cell Acute Lymphoblastic Leukemia	withdrawn	Phase 1 / Phase 2	0	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	0	May 14, 2026	clinicaltrials
NCT05909527	A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma	withdrawn	Phase 1 / Phase 2	0	Guangzhou Bio-gene Technology Co., LtdINDUSTRY	1	Mar 17, 2026